Therapeutic Effects of Medicinal Mushrooms on Gastric, Breast, and Colorectal Cancer: A Scoping Review

Amit Dan1, Robyn Swain1, Seigna Belonce1

  • 1Department of Nutrition, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.

Cureus
|May 16, 2023
PubMed

Insights

Medicinal mushrooms show promise as complementary cancer treatments, potentially reducing side effects and improving survival for gastric, breast, and colorectal cancers. Further research is needed to confirm efficacy and optimal dosages.

Area of Science:

  • Oncology
  • Pharmacology
  • Integrative Medicine

Background:

  • Cancer remains a leading global cause of mortality.
  • Conventional anticancer treatments often cause severe adverse effects.
  • Exploring alternative therapies with fewer side effects, such as medicinal mushrooms, is crucial.

Purpose of the Study:

  • To conduct a scoping review of recent evidence on the therapeutic applications of medicinal mushrooms in cancer treatment.
  • To focus on cancers with high mortality rates: gastric, breast, and colorectal cancers.

Main Methods:

  • Searched Embase, Ovid MEDLINE, CINAHL, and Alt HealthWatch for studies published 2012-2023.
  • Included randomized controlled trials, clinical trials, and retrospective cohort studies with human subjects.
  • Selected nine articles meeting inclusion criteria for final review.

Main Results:

  • Medicinal mushrooms, including Shiitake, Turkey Tail, and Scaly Wood, demonstrated efficacy in treating cancer symptoms and side effects.
  • Observed benefits include prevention of lymph node metastasis, prolonged survival, and reduced chemotherapy-induced side effects.
  • Findings suggest positive effects on the immune system, immune function, and quality of life.

Conclusions:

  • Medicinal mushrooms show potential as an adjunct therapy for gastric, breast, and colorectal cancers.
  • They may help manage treatment side effects and improve patient outcomes.
  • Further large-scale randomized controlled trials are necessary to establish optimal dosages and confirm efficacy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K